GHK-Cu vs KPV
GHK-Cu and KPV are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.
How they actually differ
Comparing the two: GHK-Cu is tripeptide-copper(ii) complex (gly-his-lys : cu²⁺), while KPV is tripeptide (lys-pro-val), alpha-msh c-terminal fragment — different molecular classes with different handling consequences; they call for different primary diluents (sterile or bacteriostatic water versus bacteriostatic water (0.9% benzyl alcohol)); their leading degradation routes differ (copper dissociation at acidic ph for GHK-Cu, adsorptive loss to plasticware at very low working concentrations for KPV), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
GHK-Cu — origin
GHK was identified by Loren Pickart in 1973 as a factor in human plasma whose concentration declines markedly with age. The decisive later finding was that its activity depends on chelated copper(II) — the peptide and the metal function as a unit. GHK-Cu is therefore a coordination complex, not simply a peptide, and it is the only such compound in this catalogue.
KPV — origin
KPV is the three-residue C-terminal tail of alpha-melanocyte-stimulating hormone. It retains the anti-inflammatory character associated with the parent hormone while lacking the melanocortin-receptor region responsible for pigmentation — the reason it is studied for inflammation without a tanning effect.
GHK-Cu research themes
The best-populated area of the GHK-Cu literature, examined in dermal fibroblast models.
Studied for effects on the MMP/TIMP balance governing matrix turnover.
Copper itself is an angiogenic cofactor, and the complex is studied in that context.
Plasma GHK falls substantially between early and later adulthood, a finding central to research interest in the molecule.
KPV research themes
Studied for modulation of inflammatory pathways such as NF-kB in cell and tissue models, inherited from the alpha-MSH parent.
A significant share of the literature examines gut-inflammation research models.
Investigated in dermal and tissue-repair contexts without the pigmentation activity of the full hormone.
GHK-Cu handling
- Never reconstitute in acidic diluent — low pH dissociates the copper complex.
- Keep chelating agents such as EDTA out of any buffer used with this compound.
- Treat colour change as a discard signal: clear blue is correct, pale or green is not.
- Avoid contact with reducing agents, which will reduce Cu(II) to Cu(I) and collapse the complex.
KPV handling
- Reach room temperature before opening.
- Use low-bind labware at very low working concentrations to limit adsorption.
- Label aliquots with reconstitution date and diluent.
Both third-party tested
Every Popular Peptides batch of GHK-Cu and KPV is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
GHK-Cu reference
Related comparisons
GHK-Cu and KPV are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.